• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[估算妥布霉素有效给药剂量的临床实验室方法。纸片药敏试验体外最低抑菌浓度折点的重新评估]

[Clinical laboratory approach for estimating effective administrative dose of tobramycin. Reevaluation of in vitro MIC break points of disk susceptibility test].

作者信息

Uete G, Matsuo K, Uete T

机构信息

Department of Clinical Investigation, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka.

出版信息

Jpn J Antibiot. 1989 Sep;42(9):1888-99.

PMID:2810752
Abstract

The reliability of the tobramycin (TOB) disc susceptibility test in estimating approximate values of MICs was studied using various clinical isolates totaling 261 strains and using Showa discs (8 mm diameter containing 30 micrograms of TOB) and Difco discs (6 mm diameter containing 10 micrograms of TOB). Clinical significance of a 4 category system for the interpretation of the disc tests, which is widely used in Japan, and that of a 3 category system used in USA and Europe, were also evaluated to determine which system would be more suitable for the evaluation of proper dose levels of administration. Furthermore, the evaluation was made using these discs with respect to the in vitro MIC break points for therapeutic use of antibiotics proposed by the British Society for Antimicrobial Chemotherapy (J. Antimicr. Chemoth. 21:701-710, 1988). The results obtained with the disc method were compared with MICs determined using the agar dilution method at an inoculum level of 10(6) CFU/ml. The results of the TOB disc susceptibility test either with Showa or Difco discs were well correlated with MICs, showing the reliability of the disc method to estimate approximate values of MICs. Break points in MIC values proposed for the classification of bacteria into the 4 categories of susceptibility are () MIC less than or equal to 2 micrograms/ml, (++) MIC greater than 2-10 micrograms/ml, (+) MIC greater than 10-50 micrograms/ml, (-) MIC greater than 50 micrograms/ml. Those proposed in the 3 categories of susceptibility are Sensitive (S) MIC less than or equal to 4 micrograms/ml, Intermediate (I) MIC greater than 4-8 micrograms/ml, Resistance (R) MIC greater than 8 micrograms/ml. In the 4 category classification system of the Showa disc susceptibility test, 16 out of 261 strains (6.1%) tested showed false positive results and 7 (2.7%) did false negative results. If the classification was modified as follows: ( ) MIC less than or equal to 3 micrograms/ml, (++) MIC greater than 3-15 micrograms/ml, (+) MIC greater than 15-60 micrograms/ml, (-) MIC greater than 60 micrograms/ml, false positive results were markedly reduced. Only 6 out of 261 strains (2.3%) showed false positive results, and 7 (2.7%) did false negative results. With Difco disc, in the 4 category interpretation system, 8 out of 261 strains (3.1%) tested showed false positive and 35 (13.4%) did false negative results. No inhibitory zones were observed against a majority of strains with MIC greater than 25 micrograms/ml, thus unable to assess (+) susceptibility.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

使用总共261株不同的临床分离菌株,采用昭和药敏纸片(直径8 mm,含30微克妥布霉素)和迪夫科药敏纸片(直径6 mm,含10微克妥布霉素),研究了妥布霉素(TOB)纸片药敏试验在估计最低抑菌浓度(MIC)近似值方面的可靠性。还评估了在日本广泛使用的用于解释纸片试验的4分类系统以及在美国和欧洲使用的3分类系统的临床意义,以确定哪种系统更适合评估合适的给药剂量水平。此外,使用这些纸片对抗菌化疗英国协会提出的抗生素治疗用体外MIC折点进行了评估(《抗菌化疗杂志》21:701 - 710, 1988)。将纸片法获得的结果与接种量为10(6) CFU/ml时使用琼脂稀释法测定的MIC进行比较。使用昭和或迪夫科纸片进行的TOB纸片药敏试验结果与MIC相关性良好,表明纸片法在估计MIC近似值方面的可靠性。用于将细菌分为4类药敏的MIC值折点为:()MIC小于或等于2微克/毫升,(++)MIC大于2 - 10微克/毫升,(+)MIC大于10 - 50微克/毫升,( - )MIC大于50微克/毫升。3类药敏中提出的折点为:敏感(S)MIC小于或等于4微克/毫升,中介(I)MIC大于4 - 8微克/毫升,耐药(R)MIC大于8微克/毫升。在昭和纸片药敏试验的4分类系统中,261株受试菌株中有16株(6.1%)出现假阳性结果,7株(2.7%)出现假阴性结果。如果将分类修改如下:()MIC小于或等于3微克/毫升,(++)MIC大于3 - 15微克/毫升,(+)MIC大于15 - 60微克/毫升,( - )MIC大于60微克/毫升,则假阳性结果明显减少。261株中只有6株(2.3%)出现假阳性结果,7株(2.7%)出现假阴性结果。对于迪夫科纸片,在4分类解释系统中,261株受试菌株中有8株(3.1%)出现假阳性,35株(13.4%)出现假阴性结果。对于大多数MIC大于25微克/毫升的菌株未观察到抑菌圈,因此无法评估(+)药敏情况。(摘要截于400字)

相似文献

1
[Clinical laboratory approach for estimating effective administrative dose of tobramycin. Reevaluation of in vitro MIC break points of disk susceptibility test].[估算妥布霉素有效给药剂量的临床实验室方法。纸片药敏试验体外最低抑菌浓度折点的重新评估]
Jpn J Antibiot. 1989 Sep;42(9):1888-99.
2
[Clinical laboratory approach in estimating effective administrative dose of piperacillin. Reevaluation of MIC break points in 3 and 4 category systems of disc susceptibility test].[评估哌拉西林有效给药剂量的临床实验室方法。对纸片药敏试验3类和4类系统中MIC折点的重新评估]
Jpn J Antibiot. 1990 Sep;43(9):1559-71.
3
[Clinical laboratory approach for estimating effective administrative dose of cephalothin. Reevaluation of MIC break points in 4 category system of disc susceptibility test].[估计头孢噻吩有效给药剂量的临床实验室方法。圆盘药敏试验4分类系统中最低抑菌浓度断点的重新评估]
Jpn J Antibiot. 1989 Sep;42(9):1900-12.
4
[Clinical laboratory approach for estimating the effective administrative dose of latamoxef. Significance of a 4-category system interpretation of the latamoxef disc susceptibility test].[用于估算拉氧头孢有效给药剂量的临床实验室方法。拉氧头孢纸片药敏试验4分类系统解释的意义]
Jpn J Antibiot. 1987 Nov;40(11):1906-16.
5
[Clinical laboratory approach to estimate effective administrative dose of minocyclin. Reevaluation of in vitro MIC break points in disc susceptibility test].[估计米诺环素有效给药剂量的临床实验室方法。纸片药敏试验中体外最低抑菌浓度(MIC)折点的重新评估]
Jpn J Antibiot. 1990 Sep;43(9):1545-58.
6
[Clinical laboratory approach to evaluate efficacy of amikacin. Reevaluation of in vitro MIC break points in disc susceptibility test].[评估阿米卡星疗效的临床实验室方法。纸片药敏试验中体外最低抑菌浓度(MIC)折点的重新评估]
Jpn J Antibiot. 1992 May;45(5):489-501.
7
[Clinical laboratory approach for estimating effective administrative dose of cefoperazone. Evaluation of disc susceptibility test and its interpretation system].[估计头孢哌酮有效给药剂量的临床实验室方法。纸片药敏试验及其解释系统的评估]
Jpn J Antibiot. 1988 Oct;41(10):1418-29.
8
[Clinical laboratory approach to evaluate administration dose of arbekacin. Reevaluation of in vitro MIC break points in the disk susceptibility test].[评估阿贝卡星给药剂量的临床实验室方法。纸片扩散法药敏试验中体外最低抑菌浓度(MIC)折点的重新评估]
Jpn J Antibiot. 1994 Aug;47(8):1041-52.
9
[Clinical laboratory approach in estimating the effective dosage of cefamandole].[临床实验室评估头孢孟多有效剂量的方法]
Jpn J Antibiot. 1988 Jun;41(6):631-40.
10
[Clinical laboratory approach to estimating the effective administration dose of imipenem/cilastatin. Evaluation of the disk susceptibility test and its interpretation system].[临床实验室评估亚胺培南/西司他丁有效给药剂量的方法。纸片药敏试验及其解读系统的评估]
Jpn J Antibiot. 1989 Nov;42(11):2377-92.